Health News
FDA Expands Opdivo Approval
The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) non-small cell lung cancer whose disease progressed during or after platinum-based chemotherapy.
Think Pink!
Have you or your loved ones been affected by breast cancer? Share these resources and support those fighting!
All About Breast Cancer
October is Breast Cancer Awareness Month - a perfect time to learn a bit more about the condition that affects roughly 1 in 8 US women, according to the National Cancer Institute. So read on and wear your pink ribbon proudly!
How to Save Face: Mohs Micrographic Surgery
Many skin cancers occur on the face. Removing them is vital, but it can be disfiguring. That's where Mohs micrographic surgery could step in.
Melanoma Rx May Treat Lung Cancer, Too
Turns out a melanoma medication could also help patients with a different type of cancer.
Advanced Non-Small Cell Lung Cancer Rx Approved
The U.S. Food and Drug Administration today granted accelerated approval for Keytruda (pembrolizumab) to treat patients with advanced (metastatic) non-small cell lung cancer (NSCLC) whose disease has progressed after other treatments and with tumors that express a protein called PD-L1. Keytruda is approved for use with a companion diagnostic, the PD-L1 IHC 22C3 pharmDx test, the first test designed to detect PD-L1 expression in non-small cell lung tumors.
How HRT Might Help Ovarian Cancer Patients
For ovarian cancer patients going through menopause, whether or not to take hormone replacement therapy (HRT) can be a big question. Now, these patients may have an answer.
FDA OKs Combo Skin Cancer Rx
A new FDA approval suggests that, sometimes, two medications may be better than one.
New Kidney Cancer Rx May Improve Survival
A new medication could be a game-changer for treating advanced kidney cancer.
New Kidney Cancer Rx Outperformed Standard Treatment
A new medication is showing promise for kidney cancer treatment.